KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AmortizationAmortizationAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentChange in Working CapitalChange in Working CapitalDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurora Cannabis (ACB) Cash from Financing Activities (2017 - 2025)

Aurora Cannabis has reported Cash from Financing Activities over the past 9 years, most recently at $2.1 million for Q1 2025.

  • Quarterly Cash from Financing Activities rose 158.1% to $2.1 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was -$391708.4 through Mar 2025, up 98.9% year-over-year, with the annual reading at $10453.7 for FY2025, 100.03% up from the prior year.
  • Cash from Financing Activities was $2.1 million for Q1 2025 at Aurora Cannabis, up from -$786000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $129.9 million in Q1 2021 and troughed at -$48.1 million in Q2 2021.
  • The 5-year median for Cash from Financing Activities is -$786000.0 (2024), against an average of $12.0 million.
  • Year-over-year, Cash from Financing Activities plummeted 1215.42% in 2021 and then skyrocketed 201.21% in 2022.
  • A 5-year view of Cash from Financing Activities shows it stood at -$7.4 million in 2021, then crashed by 519.11% to -$46.0 million in 2022, then soared by 124.23% to $11.1 million in 2023, then crashed by 107.06% to -$786000.0 in 2024, then skyrocketed by 367.24% to $2.1 million in 2025.
  • Per Business Quant, the three most recent readings for ACB's Cash from Financing Activities are $2.1 million (Q1 2025), -$786000.0 (Q4 2024), and $2.9 million (Q3 2024).